Pneumatosis intestinalis associated with α-glucosidase inhibitors: a pharmacovigilance study of the FDA adverse event reporting system from 2004 to 2022-Reference-Cited by-同舟云学术

Pneumatosis intestinalis associated with α-glucosidase inhibitors: a pharmacovigilance study of the FDA adverse event reporting system from 2004 to 2022

Published:2023-11-06 Issue: Volume: Page:1-10
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Chen Yiqian¹,Xiao Yao²,Lian Guanghui¹³,Yi Jun¹³,Liu Xiaowei¹³

Affiliation:

1. Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China

2. Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, Hunan, China

3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2278708

Reference49 articles.

1. Pneumatosis intestinalis: a review.

2. Pneumatosis intestinalis causing pneumoperitoneum

3. Imaging assessment and clinical significance of pneumatosis in adult patients

4. Pneumatosis Intestinalis in Necrotizing Enterocolitis

5. Pneumatosis cystoides intestinalis in Crohn's disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoglycaemic activity of the anthocyanin enriched fraction of Lycium ruthenicum Murr. Fruits and its ingredient identification via UPLC–triple-TOF-MS/MS;Food Chemistry;2024-12

2. Salvia mirzayanii and Salvia hypoleuca Essential Oils: Chemical Composition, Alpha-Glucosidase Inhibitory, and Synergistic Effects of Selected Components;Jundishapur Journal of Natural Pharmaceutical Products;2024-01-20